triple glp-1/gip/glucagon receptor agonist Retatrutide just had its biggest data year yet. In 2026, Eli Lilly's posted two major Phase 3 readouts: TRIUMPH-1 (obesity, 2,339 participants) showed a 28.3% average body weight Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling:
Description
Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A
It helps maintain your blood sugar balance and tell your brain when youre full
Targets Insulin Resistance & Weight Loss As a weight loss physician, bistroMD is the byproduct of the breakthroughs I discovered in managing insulin resistance, blood sugars, and weight
Kim, Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea, Endocrinol
